Healthcare News

September 26 2024 – AbbVie’s Parkinson’s disease drug meets main goal in late-stage trial

AbbVie's Parkinson's disease drug meets main goal in late-stage trial
Arch raises another $3B biotech fund in pursuit of ‘coolest’ new science
Biogen cuts ties with Sage on failed tremor drug
AZ gets sought-after lung cancer approval for Tagrisso
*please scroll down for all the latest news*

Check open job listings in your area

Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud
*please scroll down for all the latest news* image:

AbbVie's Parkinson's disease drug meets main goal in late-stage trial
Arch raises another $3B biotech fund in pursuit of ‘coolest’ new science
Biogen cuts ties with Sage on failed tremor drug
AZ gets sought-after lung cancer approval for Tagrisso
*please scroll down for all the latest news*

Check open job listings in your area

Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud
*please scroll down for all the latest news* image:

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

Leave a Comment

[mwai_chat window="true" fullscreen="true"]